Market World Electroceuticals Bioelectric Medicine Market | Page 2

Implantable Cardioverter Defibrillators sector is projected to hold the largest share of the global
Electroceuticals/Bioelectrical Market. Nevertheless, during the forecast period, the Retinal Implants are
anticipated to grow at the highest rate.
On the basis of type of device, the global Electroceuticals/Bioelectrical Medicine Market is classified into two
major classes: Implantable Electroceuticals Devices and Non-Invasive Electroceuticals Devices. As of 2016, the
Implantable Electroceuticals Devices dominate the largest share of the Electroceuticals/Bioelectrical Medicine
Market. On the other hand, during the forecast period, the Non-Invasive Electroceuticals Devices is estimated
to grow at the highest rate.
On the basis of end-user, the global Electroceuticals/Bioelectrical Medicine Market is classified as Hospitals,
Individual Users, and Research Institutes. In 2016, the largest market share was dominated by hospitals.
However, during the forecast period the individual users are anticipated to hold the highest share. On the basis
of application, the global Electroceuticals/Bioelectrical Medicine Market is classified as Cardiac Pacemakers,
Implantable Cardioverter Defibrillators. Transcutaneous Electrical Nerve Stimulators, Sacral Nerve Stimulators,
Spinal Cord Stimulators, Cochlear Implants, Deep Brain Stimulators, Vagus Nerve Stimulators, and the other
Electrical Stimulators, On the basis of geography, the global Electroceuticals/Bioelectrical Medicine Market is
classified as North America, Europe, Asia Pacific, and Rest of the World. North America is projected to dominate
the largest share of the global Electroceuticals/Bioelectrical Market.
Browse Full Research Report @
https://www.millioninsights.com/industry-reports/electroceuticals-bioelectric-medicine-market
The factors that attribute to the large market share by North America are growing incidences of diabetes and
cancer, rising occurrence of hearing loss, increasing prevalence of arrhythmia, high frequency of chronic
diseases, and so on. Nevertheless, during the forecast period, Asia Pacific region is anticipated to rise at the
highest growth rate owing to factors like increasing geriatric population, rising prevalence of diabetes, growing
occurrence of loss in hearing, and so on.
Some of the prominent players that fuel the growth of the global Electroceuticals/Bioelectrical Medicine Market
include Cefaly Technology, Stimwave LLC, Vomaris Innovations, Inc., EnteroMedics Inc., NeuroSigma, Inc.,
Second Sight Medical Products, Inc., ElectroCore LLC, BioElectronics Corporation, MED-EL, Oticon Medical,
Medtronic plc, St. Jude Medical, Inc., Boston Scientific Corporation, Cochlear Limited, Sonova Holding AG,
LivaNova PLC, Biotronik, and Nevro Corporation.
Market Segment: